COPD Management

Selected news for the healthcare topic - COPD Management, collected since 10/2017. We are still establishing shared news links for this healthcare topic.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics

Selected Headlines

Date Headline (link) Source Relevant Snippet
7/28/2021 Impacts of lipid-related metabolites, adiposity, and genetic background on blood eosinophil counts: the Nagahama study Nature Abstract Blood eosinophil count is a useful measure in asthma or COPD management. Recent epidemiological studies revealed that body mass index (BMI) is positively associated with eosinophil counts. However, few studies focused on the role of adiposity and fatty acid-related metabolites on eosinophil counts, including the effect of genetic polymorphism. In this community-based study involving 8265 participants (30–74 year old) from Nagahama city, we investigated the relationship ...
7/21/2021 Evaluating the implementation of a chronic obstructive pulmonary disease management program using the Consolidated Framework for Implementation Research: a case study biomedcentral.com ... it accounts for a significant portion of Canada’s annual healthcare spending. Interprofessional teams are effective at providing chronic disease management that meets the needs of patients. As part of an ongoing initiative, a COPD management program, the Best Care COPD program was implemented in a primary care setting. The objectives of this research were to determine site-specific factors facilitating or impeding the implementation of a COPD program in ...
5/14/2021 COPD Case-Finding Tool Validated, Ready for Use in Primary Care pulmonologyadvisor.com ... 2021. Researchers conducted the CAPTURE validation study by using a multimethod qualitative approach to guide longitudinal assessments and to inform strategies for implementation of the CAPTURE tool. Continue ReadingRecognizing that the enhancement of COPD management should include optimal disease identification at the primary care level, the researchers performed a thorough qualitative review of the CAPTURE tool in US primary care practice. The CAPTURE validation study included workflow reviews, patient ...
5/7/2021 Exploring the Use of Omics to Eliminate Sex and Gender Differences in COPD pulmonologyadvisor.com ... clinical phenotypes. 1 However, there have not been accompanying strides in the development of novel therapies tailored to the needs of various patient groups, which has hindered progress toward a precision medicine approach in COPD management.The exploration of biomarker-based targeted treatment strategies for COPD would benefit exponentially from the use of large-scale “Omics” — namely, genomic, epigenomic, transcriptomic, proteomic, and metabolomic data. Realizing the true value ...
5/4/2021 A Closer Look at a Team-Based Approach to Improve COPD Symptoms Physicians Weekly ... all these factors in the context of managing other chronic diseases and acute care issues during a standard 15-to-20–minute primary care provider (PCP) office visit.” The Team-Based Approach to COPD Management For a study published in the Journal of the American Board of Family Medicine , Dr. Peckens and colleagues at the West Virginia University Department of Family Medicine evaluated a team-based approach they implemented ...
4/21/2021 Helping Older People Breathe More Easily - PubMed National Institutes of Health ... priority. Moreover, in the same report, high rates of comorbidities such as dyslipidaemia, hypertension, heart disease, and cancer are noted, along with increasing emergency department presentations and increasing expenditure on drug therapy used for COPD management. [x ...
11/30/2020 Factors Affecting Community Pharmacist's Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study dovepress.com ... public health. Many studies have confirmed that the professional services for COPD patients by community pharmacists can improve comprehensive benefits. However, there’s less research investigating the factors affecting community pharmacists’ knowledge about COPD management. Therefore, this study aimed to investigate the knowledge of COPD among community pharmacists in China and analyze the factors affecting community pharmacist’s knowledge about COPD management. Methods: This study employed a face-to ...
11/20/2020 National health groups offer support for COPD patients and caregivers amid pandemic news-medical.net ... and out of the hospital, especially for those living with COPD, which is already a high-risk disease for readmissions to the hospital.” Byron Thomashow, M.D, Chief Medical Officer, COPD Foundation Questions about COPD management in the COVID era?The Centers for Disease Control and Prevention (CDC) has identified those living with COPD among those at greater risk for the most severe complications from COVID-19. To protect their ...
11/19/2020 The caregiver difference: One man’s journey caring for his father’s COPD ask.com ... as part of the support system.A new survey from GSK conducted in collaboration with CHEST and COPD Foundations identified significant gaps in communication between patients and their doctors, which create barriers to optimal COPD management. The survey, which was fielded to 351 people with COPD, 151 caregivers, 249 primary care physicians and 252 pulmonologists, found that caregivers play a valuable role in bridging these gaps and positively impact care ...
9/17/2020 Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management PR Newswire ... manage high-risk patient populations and those who may be delaying their care. Clear Arch Health announced today the addition of new connected health devices to ensure timely clinical touchpoints for COVID-19 and COPD management. The new peripherals complement the company’s already rich ecosystem of connected health devices and will provide clinical teams access to patient generated health data to better manage high-risk patient populations and those who ...
9/17/2020 Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management tmcnet.com FREE eNEWSLETTERS TMCnet News Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management [September 17, 2020] Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management BOCA RATON, Fla. , Sept. 17, 2020 /PRNewswire/ -- Clear Arch Health , a leading provider of remote patient monitoring (RPM) and mobile personal emergency response system (mPERS ...
9/1/2020 Bilim Pharmaceuticals, H&T Presspart and Hovione Collaborate contractpharma.com ... a pharmaceutical specialist in the development of innovative pulmonary device technology, are collaborating to support Bilim Pharmaceutical’s launch into the Turkish market of Ventofor Combi Fix, a formulation of Budesonide Formoterol for Asthma and COPD management, delivered by the PowdAir Plus Dry Powder Inhaler (DPI). Treating Asthma in Turkey Worldwide over 500 million people suffer from Asthma and COPD. In Turkey, there is growing patient demand for effective, readily accessible ...
8/11/2020 Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease PR Newswire ... a global initiative to raise awareness of chronic obstructive pulmonary disease ("COPD") and to improve prevention and treatment of this lung disease for patients around the world. GOLD's primary objectives include: i) Recommend effective COPD management and prevention strategies for use in all countries; ii) Increase awareness of the medical community, public health officials and the general public that COPD is a public health problem; iii) Decrease morbidity and mortality ...
8/11/2020 Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease BioSpace ... a global initiative to raise awareness of chronic obstructive pulmonary disease ("COPD") and to improve prevention and treatment of this lung disease for patients around the world. GOLD's primary objectives include: i) Recommend effective COPD management and prevention strategies for use in all countries; ii) Increase awareness of the medical community, public health officials and the general public that COPD is a public health problem; iii) Decrease morbidity and mortality ...
6/25/2020 Breztri Aerosphere Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial drugs.com ... support the strong clinical profile of Breztri Aerosphere in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of Breztri Aerosphere were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection ...
6/25/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial financialbuzz.com ... trial support the strong clinical profile of PT010 in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection. The ...
6/24/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial BioSpace ... trial support the strong clinical profile of PT010 in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection. The ...
6/24/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial gurufocus.com ... trial support the strong clinical profile of PT010 in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection. The ...
6/24/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial Business Wire ... trial support the strong clinical profile of PT010 in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection. The ...
6/5/2020 Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoring - ResearchAndMarkets.com Business Wire ... Growth Opportunities: Sound Analysis Technologies will Experience High Adoption for Remote Monitoring of Older Patients in Home Settings 3.2.5 Application Growth Opportunities: Non-contact Chronic Cough Sound Monitoring Can Play a Significant Role in COPD Management 3.3 Video Analysis Technology 3.3.1 AI-powered, Video-based Vital Signs Monitoring 3.3.2 3D Motion Tracking Technology for Estimating Heart Rate and Rhythm 3.3.3 Breathing Pattern Analysis Based on Acquired Video Data 3.3.4 Video ...